Skip to main content

Table 2 Disease comorbidities affecting more than 5% of the patients

From: Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources

Disease comorbidities

% of patients

Unspecified essential hypertension

41.62

Liver metastases

29.42

Diabetes mellitus (type I or II)

18.38

Unspecified hyperlipidaemia

18.33

Lymph nodes metastases

18.23

Respiratory failure and chronic airway obstruction

10.90

Bone metastases

10.69

Renal failure and chronic kidney disease

9.85

Anaemia

9.22

Gastrointestinal secondary neoplasm

8.97

Atrial fibrillation

6.92

Pure hypercholesterolemia

6.33

Diaphragmatic hernia

6.30

Neoplasm related pain

5.48

Obesity

5.37